We are live on ! Find out more
CTSO icon

Cytosorbents Corp
CTSO

54 hedge funds and large institutions have $20.2M invested in Cytosorbents Corp in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

2% more funds holding

Funds holding: 53 → 54 (+1)

7% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 14

0.49% more ownership

Funds ownership: 34.35% → 34.84% (+0.49%)

30% less capital invested

Capital invested by funds: $28.7M → $20.2M (-$8.48M)

Holders
54
Holders Change
+1
Holders Change %
+1.89%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
15
Reduced
14
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GIM
Granahan Investment Management
Massachusetts
+$3.07M
2
AC
Avenir Corporation
Virginia
+$496K
3
SC
Skylands Capital
Wisconsin
+$460K
4
Neuberger Berman Group
Neuberger Berman Group
New York
+$444K
5
Morgan Stanley
Morgan Stanley
New York
+$173K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$178K
2
Osaic Holdings
Osaic Holdings
Arizona
-$108K
3
Citadel Advisors
Citadel Advisors
Florida
-$57.7K
4
CM
CM Management
Florida
-$52K
5
EP
Eudaimonia Partners
Tennessee
-$44.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
CPIG
26
Chicago Partners Investment Group
Illinois
$27.4K -$8.2K -5,522 -15%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$24.9K -$43.4K -29,194 -57%
Creative Planning
28
Creative Planning
Kansas
$23.6K – – –
JIC
29
Johnson Investment Counsel
Ohio
$22.2K +$29.7K +19,971 New
VF
30
Virtu Financial
New York
$22K +$30K +20,215 New
SAM
31
Seelaus Asset Management
New Jersey
$21K -$2.23K -1,500 -7%
Charles Schwab
32
Charles Schwab
California
$17.8K – – –
OIA
33
OneDigital Investment Advisors
Kansas
$16.6K – – –
CCB
34
Country Club Bank
Missouri
$16.5K – – –
KCFA
35
Key Client Fiduciary Advisors
New Jersey
$13.3K -$1.49K -1,000 -8%
SEI Investments
36
SEI Investments
Pennsylvania
$11.5K -$5.1K -3,434 -25%
BFS
37
Bradley Foster & Sargent
Connecticut
$11.1K – – –
US Bancorp
38
US Bancorp
Minnesota
$11.1K – – –
TRCT
39
Tower Research Capital (TRC)
New York
$6.83K +$7.95K +5,352 +667%
HCP
40
Hexagon Capital Partners
Arkansas
$3.7K – – –
UBS Group
41
UBS Group
Switzerland
$3.29K +$4.11K +2,764 +1,403%
SWA
42
SOA Wealth Advisors
New York
$2.47K – – –
ASN
43
Advisory Services Network
Georgia
$2.44K +$3.27K +2,200 New
Simplex Trading
44
Simplex Trading
Illinois
$1K +$432 +291 +25%
Lazard Asset Management
45
Lazard Asset Management
New York
$1K +$1.39K +938 New
Wells Fargo
46
Wells Fargo
California
$601 +$24 +16 +3%
Comerica Bank
47
Comerica Bank
Texas
$576 +$388 +261 +101%
JP Morgan Chase
48
JP Morgan Chase
New York
$413 – – –
YAL
49
Your Advocates Ltd
Texas
$278 – – –
AF
50
Allworth Financial
California
$42 – – –
1
2
3

CTSO Hedge Fund Activity: Q4 2023 in Review

54 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2023, worth a combined $20.2M — down 30% from $28.7M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CTSO positions and 6 closed out — a net gain of 2 holders — while 15 added to existing stakes and 14 trimmed.

The largest buyer was Granahan Investment Management, adding an estimated $3.07M. The largest seller was Millennium Management, cutting an estimated $178K.

  • 54 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2023, up from 53 in Q3 2023.
  • Funds reported $20.2M of Cytosorbents Corp stock for Q4 2023, down 30% quarter-over-quarter.
  • 8 funds opened new Cytosorbents Corp positions in Q4 2023 and 6 closed out, a net change of +2 holders.
  • The largest Cytosorbents Corp buyer in Q4 2023 was Granahan Investment Management, an estimated $3.07M added.
  • The largest Cytosorbents Corp seller in Q4 2023 was Millennium Management, an estimated $178K sold.

Based on aggregated 13F filings for Q4 2023.